Effects of oxprenolol on the airways of normal and bronchitic subjects
- 1 January 1976
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 9 (4) , 259-263
- https://doi.org/10.1007/bf00561658
Abstract
In a double blind trial in 11 control subjects and 12 bronchitic patients against an inert control oxprenolol produced significant worsening in airways obstruction in 6 control and in 7 patients. There was marked individual variation in response and no way was found to predict the susceptible subjects. Objective measurement of indices of airways obstruction and the effect of oxprenolol on them is essential where there is significant respiratory impairment. Great care must continue to be exercised since a significant proportion of bronchitic patients will be adversely affected by this drug.This publication has 13 references indexed in Scilit:
- Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue.BMJ, 1975
- Untoward effects associated with practolol administration: oculomucocutaneous syndrome.BMJ, 1975
- Cutaneous and Ocular Reactions to PractololBMJ, 1974
- Adverse reactions to propranolol in hospitalized medical patients: A report from the Boston Collaborative Drug Surveillance ProgramAmerican Heart Journal, 1973
- Treatment of Hypertension with Large Doses of the β-Adrenergic Blocking Drug Oxprenolol, Alone, and in Combination with the Vasodilatator DihydralazineClinical Science, 1973
- The Effect of Practolol (‘Eraldin’) in the Long-Term Treatment of Severe and Moderate HypertensionClinical Science, 1973
- Effects of -Adrenergic Receptor Blockade on Airway Conductance and Lung Volume in Normal and Asthmatic SubjectsBMJ, 1969
- A COMPARISON OF THE EFFECT ON AIRWAY RESISTANCE OF A NEW BETA BLOCKING DRUG, ICI.50,172 AND PROPRANOLOLBritish Journal of Anaesthesia, 1968
- [Effect of 2 beta-blocking agents, propranolol and 39.089-BA, on the ventilatory function of asthmatics].1968
- EFFECT OF A β-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICSThe Lancet, 1964